Juvignac, France

Natacha Prevost


 

Average Co-Inventor Count = 5.5

ph-index = 1


Location History:

  • Montbazin, FR (2017)
  • Juvignac, FR (2018)

Company Filing History:


Years Active: 2017-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of Natacha Prevost

Introduction

Natacha Prevost is a distinguished inventor based in Juvignac, France. With a total of three patents to her name, she has made significant contributions to the field of pharmacology. Her research primarily focuses on the development of innovative compounds that address critical health issues, including cancer and neurodegenerative disorders.

Latest Patents

Among her notable inventions are her latest patents for N-(heteroaryl)-sulfonamide derivatives, which are identified as useful S100-inhibitors. These compounds, characterized by a specific formula (I), serve as inhibitors of interactions between S100A9 and its interaction partners, including RAGE, TLR4, and EMMPRIN. As such, these compounds hold promise for the treatment of various disorders such as cancer, autoimmune disorders, inflammatory disorders, and neurodegenerative disorders. The pharmaceutical compositions comprising these compounds are paving the way for advancements in therapeutic strategies.

Career Highlights

Natacha Prevost works at Active Biotech AB, a company known for its commitment to developing innovative therapeutic solutions. Throughout her career, she has demonstrated an impressive ability to transfer her scientific expertise into practical applications that can significantly impact medical treatments.

Collaborations

Collaboration has been key to Prevost's success. She has worked alongside esteemed colleagues, including David Liberg and Stephen East, which has fostered a productive research environment. These partnerships have been instrumental in advancing her projects toward successful patent submissions.

Conclusion

Natacha Prevost exemplifies the spirit of innovation in the field of pharmacology. Her groundbreaking work in developing S100-inhibitors showcases her dedication to improving healthcare solutions. As she continues to explore new avenues for research and development, her contributions serve as an inspiration to fellow inventors and researchers alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…